Tamoxifen Citrate (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Tamoxifen Citrate drug offered from Actavis Pharma, Inc.. This Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Tamoxifen Citrate |
SUBSTANCE NAME: | TAMOXIFEN CITRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-08-15 |
END MARKETING DATE: | 0000-00-00 |
Tamoxifen Citrate HUMAN PRESCRIPTION DRUG Details:
Item Description | Tamoxifen Citrate from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2011-08-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-2472_9edb57a6-23a2-4fb2-bf7f-a08dc06624c4 |
PRODUCT NDC: | 0591-2472 |
APPLICATION NUMBER: | ANDA070929 |
Other TAMOXIFEN CITRATE Pharmaceutical Manufacturers / Labelers: